ATE151776T1 - Cytotoxische und antivirale verbindung - Google Patents

Cytotoxische und antivirale verbindung

Info

Publication number
ATE151776T1
ATE151776T1 AT94300780T AT94300780T ATE151776T1 AT E151776 T1 ATE151776 T1 AT E151776T1 AT 94300780 T AT94300780 T AT 94300780T AT 94300780 T AT94300780 T AT 94300780T AT E151776 T1 ATE151776 T1 AT E151776T1
Authority
AT
Austria
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
AT94300780T
Other languages
English (en)
Inventor
Paul J Schauer
Mark T Hamann
Dolores G Gravalos
De Tres Cantos Poligono
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of ATE151776T1 publication Critical patent/ATE151776T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94300780T 1993-02-03 1994-02-02 Cytotoxische und antivirale verbindung ATE151776T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
ATE151776T1 true ATE151776T1 (de) 1997-05-15

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94300780T ATE151776T1 (de) 1993-02-03 1994-02-02 Cytotoxische und antivirale verbindung

Country Status (11)

Country Link
EP (1) EP0610078B1 (de)
JP (1) JP3452628B2 (de)
AT (1) ATE151776T1 (de)
AU (1) AU677258B2 (de)
CA (1) CA2114859C (de)
DE (1) DE69402576T2 (de)
DK (1) DK0610078T3 (de)
ES (1) ES2102772T3 (de)
GB (1) GB9302046D0 (de)
GR (1) GR3024028T3 (de)
ZA (1) ZA94748B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
NZ525243A (en) 2000-10-31 2005-01-28 Pharma Mar S A lyophilised formulation comprising kahalalide F, a peptide isolated from a herbivorous marine species of mollusc, Elysia rufescens, to treat cancer
RU2292216C2 (ru) * 2000-10-31 2007-01-27 Фарма Мар, С.А. Кахалалид f
EP1435990A1 (de) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalid-verbindungen zur verwendung in der krebstherapie
EP1572726B1 (de) * 2002-10-18 2010-12-08 Pharma Mar, S.A.U. 4-methylhexanoic kahalalide f verbindung
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
KR101149095B1 (ko) * 2002-10-18 2012-05-30 파르마 마르 에스.에이.유. 4-메틸헥사노 카할라리드 f 화합물
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
EP2262522A1 (de) * 2008-03-07 2010-12-22 Pharma Mar, S.A. Verbesserte antitumorale behandlungen
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358418B1 (de) * 1988-09-05 1992-12-16 Sankyo Company Limited Cyclisches Peptid, seine Herstellung und seine Verwendung zur Behandlung von cardiovasculären Störungen
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
DK0610078T3 (da) 1997-10-20
CA2114859A1 (en) 1994-08-04
EP0610078B1 (de) 1997-04-16
AU677258B2 (en) 1997-04-17
AU5491194A (en) 1994-08-11
GB9302046D0 (en) 1993-03-24
DE69402576D1 (de) 1997-05-22
GR3024028T3 (en) 1997-10-31
CA2114859C (en) 2008-04-15
DE69402576T2 (de) 1997-10-02
JPH0770185A (ja) 1995-03-14
JP3452628B2 (ja) 2003-09-29
ES2102772T3 (es) 1997-08-01
EP0610078A1 (de) 1994-08-10
ZA94748B (en) 1994-09-29

Similar Documents

Publication Publication Date Title
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
FI905983A0 (fi) Aminosyraderivat.
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
DK0604910T3 (da) Phosphonooxymethylethere af taxanderivater
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
SE8704298D0 (sv) Compounds for use in therapy
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
FI924397A0 (fi) Substituerade pyrimidiner.
DE69402576D1 (de) Cytotoxische und antivirale Verbindung
DE69429591D1 (de) Therapeutisch wirksame Verbindungen
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
CA2152771A1 (en) 7-o-ethers of taxane derivatives
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
IL107321A0 (en) Substituted azetidinones, their preparation and pharmaceutical compositions comprising them
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
EP0551844A3 (de)
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
ITRM920930A1 (it) Impiego del glutatione per la preparazione di composizioni farmaceutiche ad attivita' antivirale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification